Articles - Setterwalls

Articles

News to help keep you a step ahead.

Our latest articles

Stay up to date on current topics by reading articles written by our experienced lawyers. Search for the area of expertise that you are interested in.

Category Activities in the public sectorAutomotive industryBanking and financeBuilding & constructionChina deskCommerce & consumerCommercial agreementsCompliance & InvestigationsConstruction contract lawCorporate lawCOVID-19 | CoronavirusetDefence and securityDispute resolutionEmployment and pension lawEnergy & commoditiesEnvironmental lawEquity Capital MarketsEU & Competition lawFinTechInfrastructureInsolvency, restructuring and bankruptcyIntellectual property, marketing and media lawIT law and data protectionIT, technology & telecomsLife SciencesMergers & Acquisitions, M&APrivate EquityPublic procurementReal Estate LawTax lawTransport

Year202520242023202220212020201920182017201620152014

Article | 1 December 2025

M & A

“A combination of professional excellence, personal engagement and a tight relationship.”

Legal 500
Energy & commodities

“A full-service firm with an excellent track record in energy services and permitting.”

Legal 500
Tax law

“All-round knowledge and international network.”

Chambers Europe
Dispute resolution

“Clear, crisp, short and no nonsense advice.”

Legal 500
M & A

“Dedicated, enduring staff with strong attention for details”

Legal 500

News to help keep you a step ahead.

Our latest articles

Setterwalls’ Environmental Law Experts Contribute to the Chambers Environmental Law Guide 2025

Setterwalls Life Sciences Report November 2025

Two Judgments on Sales of Alcoholic Beverages in Sweden on Producers’ Sites – Opening Hours Are Not Required t…

A brief update on Sweden’s adaptations to the AI Act – SOU 2025:101

Proposal for a new Swedish product liability act – what does it mean?

Do not call it probiotics

A closer look at MDCG 2025-4 guidance for medical software apps

EU Court clarifies front‑of‑pack nutrition labelling for foods for special medical purposes: per‑portion figur…

Updates in the ethical rules – how are pharmaceutical companies affected?

Two years with FDI screening in an uncertain geopolitical environment – how did it actually turn out?